B. Petricevic et al., “Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HE/neu breast cancer patients,” Journal of Translational Medicine, vol. 11. Springer Nature, 2013.